|Articles|January 18, 2002
New CBER Guidance, Posted 11 January 2002
Author(s)BioPharm International Editors
Guidance for Industry: General Principles of Software Validation; Final Guidance for Industry and FDA Staff
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
2
How Mitigation and Maintenance Protect Against Future Risk
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
Navigating the Next Wave of Biopharma Manufacturing Innovation
5
